Headaches are common sources of pain that affect nearly every person on the planet at some point. There are several types of headaches, and they have different causes and treatments. A tension ...

PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (NYSE MKT: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug ...

Butalbital-acetaminophen-caffeine (BAC) is a prescription medication used to treat tension headaches. Although not Food and Drug Administration (FDA)-approved to treat migraine, doctors sometimes ...

Fioricet is currently approved for the relief of tension headache. Lannett intends to start shipping its generic version in October 2012. As per IMS Health, total sales at average wholesale price (AWP ...

Lannett Company announced that the FDA has approved its Abbreviated New Drug Application (ANDA) for Butalbital, Acetaminophen, and Caffeine Tablets, the generic of Watson‘s Fioricet. It consists of ...

Lannett has received the Food and Drug Administration’s clearance for butalbital, acetaminophen and caffeine, or BAC, capsules in two dosage strengths. The two dosage strengths of BAC capsules — 50 mg ...

The Food and Drug Administration has cleared Strides Pharma’s butalbital, acetaminophen, caffeine, and codeine phosphate capsules. Strides' product is a generic of Teva’s Fioricet with Codeine ...

Qualitest Pharmaceuticals Issues Voluntary, Nationwide Retail Level Recall of Four Lots of Butalbital, Acetaminophen, and Caffeine Tablets, USP 50mg/325mg/40mg and Four Lots of Hydrocodone Bitartrate ...

Strides Pharma Science has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Singapore, has received approval for butalbital, acetaminophen, caffeine, and codeine ...

Mutual Pharmaceutical has received FDA approval of its Abbreviated New Drug Application (ANDA) for Butalbital 50mg/Acetaminophen 325mg/Caffeine 40mg tablets. Mutual's Butalbital 50mg/Acetaminophen ...

Lannett Company, Inc. ( LCI) recently announced that the US Food and Drug Administration (FDA) granted approval to the company's abbreviated new drug application (ANDA) for its generic version of ...